India to Kenya: Saxagliptin Export Trade Route

The India to Kenya Saxagliptin corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $2.1K USD. The route is dominated by ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED, which alone accounts for roughly 68% of all export value, reflecting the consolidated nature of India's saxagliptin manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $531 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with saxagliptin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 14.0%, placing it at rank #12 among India's top saxagliptin export destinations globally.

On the import side, key buyers of Indian saxagliptin in Kenya include TO THE CONSIGNEE-, TO THE MANGER, TO THE ORDER OF. TO THE CONSIGNEE- is the single largest importer with 2 shipments valued at $1.5K USD.

India's saxagliptin exports to Kenya are driven primarily by a handful of large-scale manufacturers. ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED, GOVADALU BILATERAL, DOSHI MEDICARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $531 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as asper invoice no: zppl/xp/2324/222 date:02/12/2023 sr no. 9 saxagliptin tablets2.5mg and harmless medicine for human consumptionsaxagliptin (5mg) + metformin (1000mg) kombiglyze 5/1000 tab 7's-batch no.wa0039, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE CONSIGNEE- is the largest importer with 2 shipments worth $1.5K USD — representing 68% of all saxagliptin imports from India on this route.